Bonini S, Tomassini M, Adriani E, Magrini L, Rumi C, Bussa S, Ronchetti F, Bonini S
Andrea Cesalpino Foundation, Institute of 1st Clinica Medica, University La Sapienza, Rome, Italy.
Allergy. 1993;48(17 Suppl):133-7; discussion 143-5. doi: 10.1111/j.1398-9995.1993.tb04716.x.
The paper reviews personal studies aimed at identifying clinical markers of eosinophil inflammation in allergic diseases. Preliminary data on the use of flow cytometry as a method to detect eosinophil activation through phenotypic activation markers are reported. The concept of eosinophil releasibility is introduced on the basis of in vitro eosinophil activation and mediator release by different stimuli. Data showing an increase of serum levels of ECP mainly in subjects with sensitivity to perennial allergens and related to histamine bronchial reactivity are discussed in view of their practical impact in diagnosing and monitoring of allergic diseases and asthma.
本文回顾了旨在确定过敏性疾病中嗜酸性粒细胞炎症临床标志物的个人研究。报告了关于使用流式细胞术作为通过表型激活标志物检测嗜酸性粒细胞活化方法的初步数据。基于体外嗜酸性粒细胞由不同刺激物激活和介质释放,引入了嗜酸性粒细胞释放性的概念。鉴于其在过敏性疾病和哮喘诊断及监测中的实际影响,讨论了主要在对常年性变应原敏感且与组胺支气管反应性相关的受试者中血清嗜酸性粒细胞阳离子蛋白(ECP)水平升高的数据。